Kiryat Hamada Street 5
Jerusalem 9777605
Israel
972 3 577 4115
https://www.alphatau.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 121
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Uzi Sofer | CEO & Chairman | 630k | N/D | 1970 |
Mr. Raphi Levy | Chief Financial Officer | 424k | N/D | 1985 |
Mr. Amnon Gat | Chief Operations Officer | 340k | N/D | 1975 |
Mr. Peter M. Melnyk | Chief Commercial Officer | 376k | N/D | 1962 |
Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board | 401k | N/D | 1979 |
Mr. Ronen Segal | Chief Technology Officer | 380k | N/D | 1973 |
Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board | N/D | N/D | 1947 |
Ms. Rebecca Becker | Vice President of legal | N/D | N/D | N/D |
Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board | N/D | N/D | 1940 |
Ms. Yael Zeiger | Corporate Controller | N/D | N/D | 1983 |
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
La calificación ISS Governance QuickScore de Alpha Tau Medical Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.